Name | Number of supported studies | Average coverage | |
---|---|---|---|
smooth muscle cell | 16 studies | 26% ± 8% | |
endothelial cell | 16 studies | 26% ± 9% | |
basal cell | 13 studies | 30% ± 13% | |
fibroblast | 11 studies | 27% ± 9% | |
myofibroblast cell | 10 studies | 26% ± 9% | |
astrocyte | 10 studies | 30% ± 13% | |
endothelial cell of lymphatic vessel | 9 studies | 25% ± 7% | |
pericyte | 9 studies | 24% ± 6% | |
endothelial cell of vascular tree | 7 studies | 22% ± 4% | |
connective tissue cell | 6 studies | 23% ± 6% | |
epithelial cell | 6 studies | 34% ± 15% | |
endothelial cell of artery | 5 studies | 23% ± 6% | |
vein endothelial cell | 5 studies | 20% ± 3% | |
ciliated cell | 5 studies | 32% ± 9% | |
secretory cell | 4 studies | 25% ± 13% | |
capillary endothelial cell | 4 studies | 19% ± 2% | |
type I pneumocyte | 4 studies | 27% ± 8% | |
glutamatergic neuron | 4 studies | 33% ± 18% | |
goblet cell | 4 studies | 19% ± 4% | |
club cell | 3 studies | 22% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 4789.39 | 1445 / 1445 | 100% | 7.22 | 183 / 183 |
ovary | 100% | 3859.44 | 180 / 180 | 100% | 9.60 | 430 / 430 |
brain | 100% | 4228.09 | 2641 / 2642 | 100% | 18.60 | 703 / 705 |
prostate | 100% | 3192.99 | 245 / 245 | 100% | 13.25 | 500 / 502 |
breast | 100% | 3804.29 | 459 / 459 | 99% | 11.41 | 1112 / 1118 |
skin | 100% | 4030.20 | 1809 / 1809 | 99% | 8.50 | 469 / 472 |
intestine | 100% | 3076.64 | 965 / 966 | 99% | 8.87 | 523 / 527 |
thymus | 100% | 3810.46 | 653 / 653 | 99% | 14.39 | 597 / 605 |
lung | 99% | 2315.59 | 570 / 578 | 100% | 9.49 | 1153 / 1155 |
bladder | 100% | 4576.19 | 21 / 21 | 98% | 9.92 | 496 / 504 |
stomach | 99% | 2584.30 | 357 / 359 | 99% | 7.42 | 282 / 286 |
uterus | 100% | 5054.41 | 170 / 170 | 98% | 11.17 | 450 / 459 |
kidney | 100% | 2317.74 | 89 / 89 | 98% | 9.06 | 883 / 901 |
adrenal gland | 100% | 1914.82 | 257 / 258 | 93% | 7.35 | 214 / 230 |
pancreas | 90% | 970.88 | 296 / 328 | 99% | 10.34 | 176 / 178 |
liver | 96% | 1241.48 | 218 / 226 | 86% | 3.84 | 349 / 406 |
adipose | 100% | 3755.23 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 5524.05 | 1335 / 1335 | 0% | 0 | 0 / 0 |
spleen | 100% | 2062.37 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 5.85 | 1 / 1 |
eye | 0% | 0 | 0 / 0 | 99% | 9.43 | 79 / 80 |
tonsil | 0% | 0 | 0 / 0 | 98% | 7.96 | 44 / 45 |
heart | 96% | 1790.41 | 825 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 90% | 4.05 | 26 / 29 |
muscle | 79% | 783.86 | 637 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 26% | 275.23 | 243 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0005925 | Cellular component | focal adhesion |
GO_0005768 | Cellular component | endosome |
GO_0046872 | Molecular function | metal ion binding |
GO_0005515 | Molecular function | protein binding |
Gene name | ZFYVE21 |
Protein name | Zinc finger FYVE domain-containing protein 21 (ZF21) Zinc finger FYVE-type containing 21 |
Synonyms | |
Description | FUNCTION: Plays a role in cell adhesion, and thereby in cell motility which requires repeated formation and disassembly of focal adhesions. Regulates microtubule-induced PTK2/FAK1 dephosphorylation, an event important for focal adhesion disassembly, as well as integrin beta-1/ITGB1 cell surface expression. . |
Accessions | ENST00000553512.5 G3V2M2 ENST00000311141.7 [Q9BQ24-1] ENST00000555163.2 G3V5D6 ENST00000216602.10 [Q9BQ24-2] ENST00000556610.5 R4GN42 Q9BQ24 |